LPC-233

N/A

Report date: 2025/01/26 18:18:50
NME

Base Information

Drug NameLPC-233
Drug Alias NameLpxC inhibitor (ValanBio)LPC-233
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitors
TargetsUDP-3-O-acyl-N-acetylglucosamine deacetylase
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesValanBio Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesValanBio Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A